3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Myasthenia Gravis
1
Interventions
pembrolizumab
2
Standard of Care
2
Methods
2
Interviews as Topic
2
Educational Status
2
Early Intervention, Educational
2
Counseling
2
Blood Specimen Collection
2
zilucoplan
1
sacituzumab govitecan
1
rozanolixizumab
1
oxycodone-acetaminophen
1
ibrutinib
1
erdafitinib
1
enzalutamide
1
enfortumab vedotin
1
dynorphin-converting endopeptidase
1
durvalumab
1
brexucabtagene autoleucel
1
axicabtagene ciloleucel
1
avelumab
1
Vinblastine
1
Tramadol
1
Surgical Procedures, Operative
1
Stents
1
Specimen Handling
1
Semen Analysis
1
Robotic Surgical Procedures
1
Protons
1
Pregabalin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
zilucoplan
×
30 days
×
Clear all
NCT06435312
2026-05-08
ziMyG+
UCB Pharma
Phase 3
Enrolling by invitation
8 enrolled